Literature DB >> 23999423

Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.

Satu Heliövaara-Peippo1, Ritva Hurskainen, Juha Teperi, Anna-Mari Aalto, Seija Grénman, Karoliina Halmesmäki, Markus Jokela, Aarre Kivelä, Eija Tomás, Marjo Tuppurainen, Jorma Paavonen.   

Abstract

OBJECTIVE: Menorrhagia is a common problem impairing the quality of life (QOL) of many women. Both levonorgestrel-releasing intrauterine system (LNG-IUS) and hysterectomy are effective treatment modalities but no long-term comparative studies of QOL and costs exist. The objective of this study was to compare QOL and costs of LNG-IUS or hysterectomy in the treatment of menorrhagia during 10-year follow-up. STUDY
DESIGN: A total of 236 women, aged 35-49 years, referred for menorrhagia to 5 university hospitals in Finland were randomly assigned to treatment with LNG-IUS (n = 119) or hysterectomy (n = 117) and were monitored for 10 years. The main outcome measures were health-related QOL (HRQOL), psychosocial well-being, and cost-effectiveness.
RESULTS: A total of 221 (94%) women were followed for 10 years. Although 55 (46%) women assigned to the LNG-IUS subsequently underwent hysterectomy, the overall costs in the LNG-IUS group ($3423) were substantially lower than in the hysterectomy group ($4937). Overall, levels of HRQOL and psychosocial well-being improved during first 5 years but diminished between 5 years and 10 years and the improved HRQOL returned close to the baseline level. There were no significant differences between LNG-IUS and hysterectomy groups.
CONCLUSION: Both LNG-IUS and hysterectomy improved HRQOL. The improvement was most striking during the first 5 years. Although many women eventually had hysterectomy, LNG-IUS remained cost-effective.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  cost-effectiveness; health-related quality of life; hysterectomy; levonorgestrel-releasing intrauterine system; menorrhagia

Mesh:

Substances:

Year:  2013        PMID: 23999423     DOI: 10.1016/j.ajog.2013.08.041

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

Review 2.  Menorrhagia.

Authors:  Kirsten Duckitt
Journal:  BMJ Clin Evid       Date:  2015-09-18

3.  Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)

Authors:  K J Neis; W Zubke; T Römer; K Schwerdtfeger; T Schollmeyer; S Rimbach; B Holthaus; E Solomayer; B Bojahr; F Neis; C Reisenauer; B Gabriel; H Dieterich; I B Runnenbaum; W Kleine; A Strauss; M Menton; I Mylonas; M David; L-C Horn; D Schmidt; P Gaß; A T Teichmann; P Brandner; W Stummvoll; A Kuhn; M Müller; M Fehr; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

Review 4.  Hysterectomy for Benign Uterine Disease.

Authors:  Klaus J Neis; Wolfgang Zubke; Mathias Fehr; Thomas Römer; Karl Tamussino; Monika Nothacker
Journal:  Dtsch Arztebl Int       Date:  2016-04-08       Impact factor: 5.594

Review 5.  Surgery versus medical therapy for heavy menstrual bleeding.

Authors:  Jane Marjoribanks; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2016-01-29

6.  Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.

Authors:  O Heikinheimo; P Inki; T Schmelter; K Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2014-03-28       Impact factor: 6.918

7.  Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding.

Authors:  Luis Bahamondes; Victor Marin; Silvia Ciarmatori; Agnaldo L Silva-Filho; Juan Manuel Acuña; Maria Y Makuch
Journal:  Obstet Gynecol Int       Date:  2016-08-25

Review 8.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.

Authors:  Andrea Gabrio; Alexina J Mason; Gianluca Baio
Journal:  Pharmacoecon Open       Date:  2017-06

9.  Progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-06-12

10.  Knowledge and attitudes of Latin American obstetricians and gynecologists regarding intrauterine contraceptives.

Authors:  Luis Bahamondes; Maria Y Makuch; Ilza Monteiro; Victor Marin; Richard Lynen
Journal:  Int J Womens Health       Date:  2015-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.